v3.5.0.2
4. Business Combinations (Details - Merger consideration) - Infusion [Member]
 12 Months Ended
Dec. 31, 2014
USD ($)
Business Acquisition [Line Items]  
Fair value of common shares $ 7,096,917 [1]
Reduction in note payable to IBI (450,000) [2]
Interest accrued on IBI note payable (9,237) [3]
Consideration effectively transferred $ 6,637,680
[1] Based on 78,854,625 common shares with a fair value of $0.09 per share, the closing price of ASTV common shares on April 2, 2014, the transaction closing date.
[2] Represents a series of notes issued by ASTV to IBI between December 23, 2013 and March 14, 2014 used for general working capital purposes. In the event the merger transaction was not completed by June 30, 2014, all principal and related accrued interest became payable, which was forgiven when the transaction closed.
[3] Accrued interest related to the IBI notes, accrued at 12% per annum.